← Leaderboards
Francis Charles Brunicardi
Baylor College Of Medicine
$4,785,825
Attributed
$4,785,825
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $606.5K · FY2005–12$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$4,785,825 · 4
By mechanism
R01$4,560,178 · 2
R56$220,647 · 1
R13$5,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Timothy C Thompson$13,464,867
- Susan J Marriott$7,679,762
- Lawrence Chan$23,286,228
- E Brian Butler$91,101
- Olivia M. Pereira-Smith$4,322,042
Others in their field
Top investigators on “Insulin”
- Jeffrey P Krischer · University Of South Florida$605,714,892
- John M Lachin · George Washington University$153,440,346
- David M Nathan · Massachusetts Institute Of Technology$139,041,931
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$108,827,660
- Mark A Magnuson · Vanderbilt University$79,749,111
- Jose A Luchsinger · Columbia University Health Sciences$71,267,462
Research focus
InsulinThymidine KinaseGene TherapyTranscription FactorGanciclovirHuman TissueIsletDiabetes MellitusPancreasPancreatic Islet FunctionResponsePolymerase Chain ReactionRegulationMouse ModelImageImage AnalysisHormonesLabelPositron-Emission TomographyOptic ImagingPancreatic PolypeptideDiagnosisHomeoboxMolecular Target
Grant awards (20)
PDX-1 is a Therapeutic Target for Pancreatic Cancer$218,813
R01 · FY2012 · CA · contact PI
PDX-1 is a Therapeutic Target for Pancreatic Cancer$266,570
R01 · FY2011 · CA · contact PI
PDX-1 is a Therapeutic Target for Pancreatic Cancer$274,814
R01 · FY2010 · CA · contact PI
Somatostatin Receptor Subtype 5 Regulation of Islet Neoplasia$208,647
R56 · FY2010 · DK · contact PI
Somatostatin Receptor Subtype 5 Regulation of Islet Neoplasia$12,000
R56 · FY2010 · DK · contact PI
PDX-1 is a Therapeutic Target for Pancreatic Cancer$274,814
R01 · FY2009 · CA · contact PI
PDX-1 is a Therapeutic Target for Pancreatic Cancer$274,814
R01 · FY2008 · CA · contact PI
Intraislet Communication in Surgically-Altered Pancreas$321,077
R01 · FY2007 · DK · contact PI
Intraislet Communication in Surgically-Altered Pancreas$330,667
R01 · FY2006 · DK · contact PI
Pancreatic Cancer Treatment Using Surgery & Gene Therapy$261,595
R01 · FY2006 · CA · contact PI
Intraislet Communication in Surgically-Altered Pancreas$338,625
R01 · FY2005 · DK
Pancreatic Cancer Treatment Using Surgery &Gene Therapy$267,890
R01 · FY2005 · CA
Intraislet Communication in Surgically-Altered Pancreas$338,625
R01 · FY2004 · DK
Pancreatic Cancer Treatment Using Surgery &Gene Therapy$267,890
R01 · FY2004 · CA
Pancreatic Cancer Treatment Using Surgery &Gene Therapy$267,890
R01 · FY2003 · CA
Molecular Surgeon Symposium on Pancreatic Cancer$5,000
R13 · FY2003 · CA
Pancreatic Cancer Treatment Using Surgery &Gene Therapy$267,890
R01 · FY2002 · CA
INTRA CELL COMMUNICATION IN SURGICALLY ALTERED PANCREAS$75,250
R01 · FY2002 · DK
INTRA CELL COMMUNICATION IN SURGICALLY ALTERED PANCREAS$259,503
R01 · FY2001 · DK
INTRA CELL COMMUNICATION IN SURGICALLY ALTERED PANCREAS$253,451
R01 · FY2000 · DK